Antibodies Block Migraine in Preliminary Studies HCPLive Results of 2 new studies presented at the annual meeting of the American Academy of Neurology in Philadelphia suggest humanized anti-calcitonin gene-related peptide (CGRP) antibodies may be safe and effective as treatments to prevent migraines in ... |
